Marino, A.; Stracquadanio, S.; Campanella, E.; Munafò, A.; Gussio, M.; Ceccarelli, M.; Bernardini, R.; Nunnari, G.; Cacopardo, B.
Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations. Antibiotics 2023, 12, 49.
https://doi.org/10.3390/antibiotics12010049
AMA Style
Marino A, Stracquadanio S, Campanella E, Munafò A, Gussio M, Ceccarelli M, Bernardini R, Nunnari G, Cacopardo B.
Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations. Antibiotics. 2023; 12(1):49.
https://doi.org/10.3390/antibiotics12010049
Chicago/Turabian Style
Marino, Andrea, Stefano Stracquadanio, Edoardo Campanella, Antonio Munafò, Maria Gussio, Manuela Ceccarelli, Renato Bernardini, Giuseppe Nunnari, and Bruno Cacopardo.
2023. "Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations" Antibiotics 12, no. 1: 49.
https://doi.org/10.3390/antibiotics12010049
APA Style
Marino, A., Stracquadanio, S., Campanella, E., Munafò, A., Gussio, M., Ceccarelli, M., Bernardini, R., Nunnari, G., & Cacopardo, B.
(2023). Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations. Antibiotics, 12(1), 49.
https://doi.org/10.3390/antibiotics12010049